Morgan Philbin, PhD, MHS
Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, MHS - 05/2007 Public Health
Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, PhD - 05/2013 Public Health
Columbia University Mailman School of Public Health, New York City, Postdoctoral Scholar - 05/2016 HIV/AIDS
She is Co-PI of a mixed-methods NIDA-funded R01 that is exploring the impact of general and pregnancy-specific opioid policies on substance use and substance use treatment engagement among pregnant people and their newborns. She is also PI of an R34 that is developing a patient decision aid to help minoritized women and providers choose between oral and long-acting injectable HIV medication. She is Co-I on multiple NIH-funded projects, including a COVID RADx grant focused on preventive behaviors among racial, ethnic and SGM youth, an R01 exploring how state-level social policies impact substance use outcomes for racial, ethnic and SGM youth, and two grants from the Canadian Institutes of Health focused on substance use, mental health and SGM individuals. She was recently awarded the 2021 NIH Office of Disease Prevention Early Stage Investigator Lecture Award for her work on HIV treatment and prevention.